首页> 美国政府科技报告 >Lipopolysaccharide Antigens of Pseudomonas aeruginosa and Design of Novel Vaccines
【24h】

Lipopolysaccharide Antigens of Pseudomonas aeruginosa and Design of Novel Vaccines

机译:铜绿假单胞菌脂多糖抗原及新型疫苗的设计

获取原文

摘要

The antigenic lipopolysaccharides (LPS) of the cell coats of five of the seven Fisher immunotype strains of the Gram-negative pathogen Pseudomonas aeruginosa have been characterized structurally by chemical methods involving degradation techniques, and by physical methods, notably high-field NMR spectroscopy. Of the seven Fisher types, the O-Chain structures of five of the types have been characterized in our laboratories. Partial structures for the remaining two types have been elucidated. The Gram-negative bacterium Pseudomonas aeruginosa is ubiquitous in its occurrence and is characterized by a very wide variety of strains as determined by conventional serotyping methods. Although healthy individuals normally have a high innate resistance to infection by Pseudmonas aeruginosa as a result of effective combat by matured antibodies, the organism is an opportunistic pathogen; virulent strains lead to dangerous, often fatal, infections in human subjects whose natural resistance has been lowered. Conventional treatment with antibiotics effective against Gram-positive organisms is of little value, as such therapeutic agents are unable to penetrate the lipopolysaccharide layer that forms a thick, hydrophobic outer coating of the cells in Gram-negative organisms. In view of the limited effectiveness of conventional antibiotic agents for combat of Pseudomonas infections, immunotherapeutic methods have been explored as an alternative method.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号